About 508,000 results
  2. People also ask
    Should you buy Eli Lilly (LLY) in 2024?
    Summary Eli Lilly has surged 58% in 2024, driven by breakthrough weight-loss drugs and strong earnings, with shares now trading above $900. Despite valuation concerns, LLY's high growth rate and reliable earnings make it a buy, supported by strong Q2 results and raised guidance.

    Eli Lilly: Sticking With A $1000 Target Ahead Of Q3 Earnings, New Tradi…

    seekingalpha.com
    Why did Lilly's share price rise 60% this year?
    This is thanks to Lilly's dominance in the billion-dollar weight loss drug market. Lilly's Mounjaro and Zepbound have helped revenue to soar in the double digits -- and that's resulted in a surging share price too, with the stock advancing nearly 60% so far this year. In fact, Lilly's stock has reached a level that's rare in the healthcare sector.

    Prediction: This Will be Eli Lilly's Next Big Move

    finance.yahoo.com
    Does Eli Lilly have a $1000 target for Q3 earnings?
    Eli Lilly: Sticking With A $1000 Target Ahead Of Q3 Earnings, New Trading Range Sep. 21, 2024 4:31 AM ETEli Lilly and Company (LLY) StockNVO Mike Zaccardi, CFA, CMT 6.78KFollowers Follow Summary Eli Lilly has surged 58% in 2024, driven by breakthrough weight-loss drugs and strong earnings, with shares now trading above $900.

    Eli Lilly: Sticking With A $1000 Target Ahead Of Q3 Earnings, New Tradi…

    seekingalpha.com
    Did Eli Lilly defraud Medicaid?
    Sept 18 (Reuters) - Drugmaker Eli Lilly (LLY.N) on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case accusing it of defrauding Medicaid, arguing that it was being wrongly held liable despite following its reasonable interpretation of the government health insurance program's requirements.

    Eli Lilly urges court to toss $183 mln Medicaid fraud judgment

    reuters.com
    Feedback
  3. Lilly.com
    https://www.lilly.com/news

    All News | Eli Lilly and Company

    • Investors

      The Investor Relations website contains information about Eli Lilly and …

    • Press Releases

      INDIANAPOLIS , Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company …

    • News Release

      FDA approves Lilly's Mounjaro™ (tirzepatide) injection, the first and only …

    See results only from lilly.com
  5. Lilly.com
    https://www.lilly.com/news/press-releases

    Lilly.com | Eli Lilly and Company

  6. Yahoo Finance
    https://finance.yahoo.com/quote/LLY/news

    Eli Lilly and Company (LLY) Latest Stock News & Headlines | Yahoo …

  7. Eli Lilly and Company
    https://investor.lilly.com/news-releases/news...

    News Release | Eli Lilly and Company

    Tags:
    Eli Lilly and Company
    Type 2 diabetes
    Glucagon-like peptide-1 agonist
  8. Eli Lilly and Company
    https://investor.lilly.com/news-releases/news...

    News Release | Eli Lilly and Company

    Tags:
    Eli Lilly and Company
    Indiana
  9. CNN
    https://www.cnn.com/2023/06/26/health/weight-loss...

    Next-generation drug from Eli Lilly boosts weight loss to 24

    Tags:
    Eli Lilly and Company
    Type 2 diabetes
    Meg Tirrell
  10. CNBC
    https://www.cnbc.com/2024/08/08/eli-lilly-lly...

    Eli Lilly (LLY) earnings Q2 2024 | CNBC

  11. Reuters
    https://www.reuters.com/business/healthc…

    Lilly hits record high after Mounjaro fuels forecast …

    WEBAug 8, 2023 · Eli Lilly on Tuesday raised its annual forecasts as demand for new diabetes drug Mounjaro surges ahead of a decision on its use as a weight-loss treatment, with shares soaring 18% to a record...

    Tags:
    Eli Lilly and Company
    Reuters
  12. CNBC
    https://www.cnbc.com/2023/07/17/alzheimers-eli...

    Alzheimer's drug donanemab shows positive results, Eli Lilly

  13. Reuters
    https://www.reuters.com/business/healthcare...

    Eli Lilly prepares for as many as 5 new drug launches next year

    Tags:
    Eli Lilly and Company
    Reuters
  15. Some results have been removed